Since we found that VPA/HPTA promoted pro-inflammatory M1 phenotype and increased IL-12 expression in our study, we next examined whether VPA/HPTA can activate CD8+ T cells to be involved in the anti-tumor response. Here, CD8A is linked to neoplasm.